The downgrade from Strong Buy to Outperform suggests a slightly less optimistic outlook on PRMW's stock by Raymond James, though the unchanged price target of $21 indicates that the firm still sees value in the stock. This mixed signal could lead to neutral short-term price movement as investors digest the implications.